We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+11.7%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$334B
AUM Growth
+$44B
Cap. Flow
+$10.5B
Cap. Flow %
3.13%
Top 10 Hldgs %
13.87%
Holding
10,649
New
1,223
Increased
4,779
Reduced
2,819
Closed
1,395

Sector Composition

Rank Sector Weight
1 Technology 13.13%
2 Financials 7.1%
3 Healthcare 6%
4 Consumer Discretionary 5.02%
5 Industrials 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASRV icon
8351
AmeriServ Financial
ASRV
$77.5M
$1.17K ﹤0.01%
+362
New +$1K
TPST icon
8352
Tempest Therapeutics
TPST
$13.7M
$1.17K ﹤0.01%
+20
New +$947
BFRGW icon
8353
Bullfrog AI Holdings Warrants
BFRGW
$1.17K ﹤0.01%
1,223
-13,218
-92% -$8.57K
MAIA icon
8354
MAIA Biotechnology
MAIA
$76M
$1.17K ﹤0.01%
998
+865
+650% +$1.4K
JTAIZ
8355
DELISTED
Jet.AI Inc. Merger Consideration Warrants
JTAIZ
$1.17K ﹤0.01%
1,110
+1,011
+1,021% +$619
DSJA
8356
DELISTED
Innovator Double Stacker ETF - January
DSJA
$1.16K ﹤0.01%
+39
New +$1.14K
GGLS icon
8357
Direxion Daily GOOGL Bear 1X ETF
GGLS
$14.3M
$1.15K ﹤0.01%
7
+5
+250% +$903
KPRX icon
8358
Kiora Pharmaceuticals
KPRX
$11.3M
$1.15K ﹤0.01%
246
+83
+51% +$431
NVX
8359
NOVONIX
NVX
$99M
$1.15K ﹤0.01%
+592
New +$1.11K
IVA
8360
Inventiva
IVA
$1.06B
$1.15K ﹤0.01%
+254
New +$1.03K
PVLA
8361
Palvella Therapeutics
PVLA
$1.99B
$1.14K ﹤0.01%
79
-465
-85% -$8.52K
AVNV icon
8362
Avantis All International Markets Value ETF
AVNV
$66.4M
$1.14K ﹤0.01%
+21
New +$1.08K
JULJ icon
8363
Innovator Premium Income 30 Barrier ETF July
JULJ
$13.7M
$1.12K ﹤0.01%
+45
New +$1.13K
CURO
8364
DELISTED
CURO Group Holdings Corp.
CURO
$1.12K ﹤0.01%
1,398
-838
-37% -$671
NKGNW
8365
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$1.1K ﹤0.01%
13,606
-230
-2% -$31
BOCNW
8366
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$1.1K ﹤0.01%
+55,000
New +$1.11K
GTIM icon
8367
Good Times Restaurants
GTIM
$14.6M
$1.09K ﹤0.01%
431
+378
+713% +$990
AREC icon
8368
American Resources Corp
AREC
$191M
$1.09K ﹤0.01%
734
+479
+188% +$733
DMK
8369
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$1.09K ﹤0.01%
1,562
+1,370
+714% +$795
AIMAU
8370
DELISTED
Aimfinity Investment Corp I Unit
AIMAU
$1.09K ﹤0.01%
+100
New +$1.09K
PSQH icon
8371
PSQ Holdings
PSQH
$13.9M
$1.08K ﹤0.01%
+14
New +$1.26K
GLLI
8372
DELISTED
Globalink Investment Inc. Common Stock
GLLI
$1.08K ﹤0.01%
100
ELUT icon
8373
Elutia
ELUT
$37.9M
$1.08K ﹤0.01%
500
TRX icon
8374
TRX Gold Corp
TRX
$254M
$1.08K ﹤0.01%
2,840
-87
-3% -$34
ONCT
8375
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$1.07K ﹤0.01%
100
-579
-85% -$4.17K

Similar funds

UBS Group's Q4 2023 Portfolio in Review

As of Q4 2023, UBS Group held 10,649 positions worth $334B, up 15% from $290B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2023, opening 1,223 new positions and adding to 4,779 existing holdings. Its largest new stake was Veralto: 498,566 shares worth $41M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $503M trimmed.

  • UBS Group's largest Q4 2023 buy was Veralto: 498,566 shares worth $41M.
  • UBS Group added most to UBS Group in Q4 2023, an estimated $591M increase.
  • UBS Group's biggest Q4 2023 reduction was Invesco QQQ Trust, cutting an estimated $503M.
  • UBS Group fully exited Activision Blizzard in Q4 2023, selling an estimated $370M.
  • UBS Group's ten largest holdings make up 14% of its $334B portfolio in Q4 2023.
  • UBS Group opened 1,223 new positions and closed 1,395 in Q4 2023.
  • UBS Group's portfolio value rose 15% quarter-over-quarter to $334B.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.